tiprankstipranks
Trending News
More News >

Shandong Xinhua Pharmaceutical Schedules Board Meeting to Review Q1 2025 Results

Story Highlights
Shandong Xinhua Pharmaceutical Schedules Board Meeting to Review Q1 2025 Results

Confident Investing Starts Here:

The latest update is out from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ).

Shandong Xinhua Pharmaceutical Company Limited has announced a board meeting scheduled for April 28, 2025, to consider and approve the unaudited results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder confidence.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and related services.

YTD Price Performance: -7.75%

Average Trading Volume: 2,131,863

Technical Sentiment Signal: Hold

Current Market Cap: HK$8.24B

See more data about 0719 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1